Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
1.723
-0.017 (-0.98%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about bioAffinity Technologies, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
bioAffinity Technologies News Update
February 21, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
February 06, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies In The News
January 30, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
January 23, 2024
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies In the News
January 08, 2024
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
January 05, 2024
Via
ACCESSWIRE
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...
Via
Benzinga
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
December 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
November 30, 2023
Via
Benzinga
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
November 30, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
November 28, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
November 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
November 06, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
October 10, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 04, 2023
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 21, 2023
Via
Benzinga
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
September 19, 2023
From
bioAffinity Technologies
Via
Business Wire
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
September 07, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
July 12, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
June 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 06, 2023
Via
Benzinga
bioAffinity Technologies Presents Research Findings at CYTO 2023
May 22, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports First Quarter 2023 Financial Results
May 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
May 01, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
April 25, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
April 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
March 31, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.